Results for “”

Entry Author Date Location
Takeda Pays Turnstone $120M to Start Alliance on Viral Cancer Therapies 12/19/19 New York
Ring Therapeutics Launches to Expand Gene Therapy Viral Vector Options 12/19/19 Boston
ArcherDX Raises $55M to Help Physicians Pick Best Cancer Therapies 12/18/19 Boulder/Denver
FTC Challenges PacBio Acquisition, Says Illumina is a “Monopolist” 12/18/19 San Diego
Zafgen’s Path Forward Is Reverse Merger With Chondrial Therapeutics 12/18/19 Boston
Orbiting Organoids: Research in Space to Unveil New Neurodegeneration Insight 12/18/19 National
ALS Fund Talks Investments and Strategy as it Kicks Off $100M Campaign 12/17/19 National
Triplet Therapeutics Unveils $59M to Try Hairpin Fix for Huntington’s 12/17/19 Boston
Organovo’s Demise Offers Path for Tarveda to Join the Public Markets 12/16/19 San Diego
Wave Stock Crashes After Decision to Halt Duchenne Drug Studies 12/16/19 Boston
Cell Reprogramming Startup Bit Bio Inks Pact With Charles River 12/16/19 Boston
Axsome’s Depression Drug Meets Phase 3 Goals, FDA Filing Planned 12/16/19 New York
Building a Better 3D Bioprinter: GE Healthcare and ASLS Combine Tech 12/16/19 Boston
Amarin’s Fish-Oil Pill Wins FDA Nod to Cut Heart Attack, Stroke Risk 12/13/19 New York
Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More 12/13/19 National
In an About-Face, FDA Approves Second Sarepta Muscular Dystrophy Drug 12/13/19 Boston
miRagen Restructures to Focus on Fibrosis, Inks $20M Stock Deal 12/12/19 Boulder/Denver
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning 12/12/19 National
Aspen Neuro Bags $6.5M to Test Parkinson’s Disease Stem Cell Therapy 12/12/19 San Diego
Iterum’s Antibiotic for Super Bugs Falls Short in Phase 3, Shares Sink 12/11/19 National
Flagship’s Cellarity Aims to Advance Cell Behavior-Based Therapeutics 12/11/19 Boston
KalVista Pharma Eye Drug Partnered With Merck Flunks Phase 2 Test 12/10/19 Boston
Zentalis Steps Out With $147M Raised to Develop “Tried and True” Small Molecules 12/10/19 National
Scripps Research, AbbVie Expand Drug Discovery Deal Beyond Cancer 12/10/19 San Diego
Perceptive Unveils New $210M Fund to Invest in Early-Stage Biotechs 12/10/19 New York
Eying Cancer Combos, Sanofi to Splash Out $2.5B on San Diego’s Synthorx 12/09/19 San Diego
Aurinia Plans FDA Filing After Lupus Nephritis Drug Hits Phase 3 Goals 12/09/19 National
Merck Makes a Big Blood Cancer Bet With $2.7B Deal for ArQule 12/09/19 New York
BridgeBio Pharma Onboards Eli Wallace to Lead Oncology Programs 12/09/19 San Francisco
Insitro Hires Serafim Batzoglou As Its First Chief Data Officer 12/09/19 San Diego
Page 3 of 1958 « previous page · next page »